Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Gilead licenses NX-1838, a new AMD treatment, to EyeTech

April 10, 2000

QLT and Ciba Vision report positive Visudyne clinical results

April 3, 2000

Neurocrine Biosciences awarded NIH grant for retinal ischemia research

April 3, 2000

Visudyne T-IND program expanded

March 20, 2000

InSite Vision's batimastat eyedrops show antiangiogenic activity

March 20, 2000

Ciba Vision seeks approval of Rescula on two continents for treatment of glaucoma

March 14, 2000

Alocril now available in U.S. for itch associated with allergic conjunctivitis

March 2, 2000

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

March 1, 2000

Allergan and Dura enter commercialization agreement for multiple products

Feb. 25, 2000

GenVec licenses gene for treating blindness

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...